VERICI DX

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark VERICI DX was filed as Word mark on 01/06/2021 at the World Intellectual Property Organization.

Trademark Details Last update: July 27, 2022

Trademark form Word mark
File reference 1576647
Countries Australia Canada Switzerland China Colombia European Community United Kingdom Israel India Japan South Korea Mexico Norway New Zealand Russia Singapore
Base trademark US No. 90038781, July 7, 2020
Application date January 6, 2021
Expiration date January 6, 2031

Trademark owner

1460 Broadway
New York NY 10036
US

Trademark representatives

1299 Pennsylvania Ave., NW, Ste. 700 Washington DC 20004 US

goods and services

05 Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes
10 Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients
42 Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis
44 Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients

Trademark history

Date Document number Area Entry
June 22, 2022 2022/25 Gaz CA Rejection
June 6, 2022 2022/23 Gaz MX Rejection
March 2, 2022 2022/10 Gaz KR Rejection
January 27, 2022 2022/4 Gaz NO Rejection
January 25, 2022 2022/4 Gaz RU Rejection
December 16, 2021 2021/50 Gaz JP Rejection
December 16, 2021 2022/3 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
November 10, 2021 2021/45 Gaz CH Rejection
October 9, 2021 2021/41 Gaz CO Rejection
October 4, 2021 2021/40 Gaz IL Rejection
September 28, 2021 2021/39 Gaz NZ Rejection
August 19, 2021 2021/33 Gaz IN Rejection
July 21, 2021 2021/29 Gaz EM Rejection
June 30, 2021 2021/26 Gaz GB Rejection
June 28, 2021 2021/26 Gaz RU Rejection
June 2, 2021 2021/22 Gaz CN Rejection
May 12, 2021 2021/19 Gaz AU Rejection
April 11, 2021 2021/16 Gaz SG Rejection
January 6, 2021 2021/5 Gaz US Registration

ID: 141576647